H.C. Wainwright Reiterates Buy Rating on Rigel Pharmaceuticals (RIGL)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 46.85 +0.88 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.97 | 52 Week High | $4.38 | |||
| Open | $46.39 | 52 Week Low | $1.88 | |||
| Day High | $47.39 | P/E | N/A | |||
| Day Low | $45.48 | EPS | $-1.12 | |||
| Volume | 167,049 | |||||
